When I found out about AncestryDNA, I thought this could be the perfect tool to pinpoint where my family emigrated over the past few hundred years (AncestryDNA can actually go back 1000 years) and give me a focus where to take my search next. When I got the email that my results were ready I felt like a kid on Christmas day. They revealed that I was only 40% British, 25% German and 35% Greek. I’ve now focused my search on these three countries and already discovered ancestors I never knew existed.
The 100,000 Genomes Project is an NHS initiative, run by Genomics England, and is the largest national genome sequencing project in the world. On entering, patients have their entire genome, of more than 3bn base pairs, sequenced. This is different from commercially available genetic testing kits, such as those from 23andMe, which only look at very small stretches of DNA in a process called genotyping. The hope of the NHS is that having so much genetic information, from so many different people, will allow “groundbreaking discoveries about how diseases work, who could be susceptible to them, how we can treat them, and what treatments might work”.
AncestryDNA is a cutting edge DNA testing service that utilises some of the latest autosomal testing technology to revolutionise the way you discover your family history. This service combines advanced DNA science with the world’s largest online family history resource to predict your genetic ethnicity and help you find new family connections. It maps ethnicity going back multiple generations and provides insight into such possibilities as: what region of Europe are my ancestors from, or am I likely to have East Asian heritage? AncestryDNA can also help identify relationships with unknown relatives through a dynamic list of DNA matches.
It’s easy to do these tests; it’s usually just a case of collecting your own samples at home, filling in short, basic questionnaires, posting the packages, and then logging on to interactive websites for confidential results (all the kits I tested used outside laboratories). With an array of price ranges and options, from one-off DNA-blitzes to targeting specific health areas, to fitness/wellness tracking, it’s no surprise that these kits are proving to be very big business and the field is primed to get even bigger, with a global market estimated to be worth around £7.7bn by 2022.